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A multicompartment biologically based dynamic model was
developed to describe the time evolution of methanol and its
metabolites in the whole body and in accessible biological matrices
of rats, monkeys, and humans following different exposure sce-
narios. The dynamic of intercompartment exchanges was de-
scribed mathematically by a mass balance differential equation
system. The model’s conceptual and functional representation was
the same for rats, monkeys, and humans, but relevant published
data specific to the species of interest served to determine the
critical parameters of the kinetics. Simulations provided a close
approximation to kinetic data available in the published literature.
The average pulmonary absorption fraction of methanol was es-
timated to be 0.60 in rats, 0.69 in monkeys, and 0.58–0.82 in
human volunteers. The corresponding average elimination half-
life of absorbed methanol through metabolism to formaldehyde
was estimated to be 1.3, 0.7–3.2, and 1.7 h. Saturation of methanol
metabolism appeared to occur at a lower exposure in rats than in
monkeys and humans. Also, the main species difference in the
kinetics was attributed to a metabolism rate constant of whole
body formaldehyde to formate estimated to be twice as high in rats
as in monkeys. Inversely, in monkeys and in humans, a larger
fraction of body burden of formaldehyde is rapidly transferred to
a long-term component. The latter represents the formaldehyde
that (directly or after oxidation to formate) binds to various en-
dogenous molecules or is taken up by the tetrahydrofolic-acid–
dependent one-carbon pathway to become the building block of
synthetic pathways. This model can be used to quantitatively
relate methanol or its metabolites in biological matrices to the
absorbed dose and tissue burden at any point in time in rats,
monkeys, and humans for different exposures, thus reducing un-
certainties in the dose-response relationship, and animal-to-hu-
man and exposure scenario comparisons. The model, adapted to
kinetic data in human volunteers exposed acutely to methanol
vapors, predicts that 8-h inhalation exposures ranging from 500 to
2000 ppm, without physical activities, are needed to increase
concentrations of blood formate and urinary formic acid above
mean background values reported by various authors (4.9–10.3
and 6.3–13 mg/liter, respectively). This leaves blood and urinary
methanol concentrations as the most sensitive biomarkers of ab-
sorbed methanol.
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Methanol is widely used as an industrial solvent and chem-
ical intermediate (Kavet and Nauss, 1990). It has also received
serious consideration as an alternative automotive fuel or fuel
additive (Health Effects Institute, 1987). Inhalation is a major
route of human exposure to methanol in the occupational and
general environments although skin exposure can occur in
certain industrial settings (Baumann and Angerer, 1979;
Downie et al., 1992; Heinrich and Angerer, 1982; Kawai et al.,
1991). Exposure to methanol also results from the consumption
of certain foodstuffs (fruits, fruit juices, certain vegetables,
aspartame sweetener, roasted coffee, honey) and alcoholic
beverages (Health Effects Institute, 1987; Jacobsen et al.,
1988).
The toxic effects of acute exposures to high methanol doses
in humans are well documented (Liesivuori and Savolainen,
1991; Røe, 1982; Tephly and McMartin, 1984; U.S. DHHS,
1993). Neurological effects, such as the initial transient depres-
sion of the central nervous system, have generally been re-
ported at blood concentrations of methanol above 6 mmol/l
(U.S. DHHS, 1993). However, the severe toxic effects are
usually associated with the production and accumulation of
formic acid, which causes metabolic acidosis and visual im-
pairment that can lead to blindness and death at blood concen-
trations of methanol above 31 mmol/l (Røe, 1982; Tephly and
McMartin, 1984; U.S. DHHS, 1993).
Although the acute toxic effects of methanol in humans are
well documented, little is known about the chronic effects of
low exposure doses, which are of interest in view of the
potential use of methanol as an engine fuel and current use as
a solvent and chemical intermediate. Gestational exposure
studies in pregnant rodents (mice and rats) have also shown
that high methanol inhalation exposures (5000 or 10,000 ppm
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and more, 7 h/day during days 6 or 7 to 15 of gestation) can
induce birth defects (Bolon et al., 1993; IPCS, 1997; Nelson et
al., 1985).
The potential deleterious effects of methanol have prompted
extensive research on its uptake and disposition in animals and
humans. This has led to the findings that pulmonary absorption
of methanol is very rapid and absorption fraction ranges from
about 60 to 85% depending on the species (Dorman et al.,
1994; Fisher et al., 2000; Horton et al., 1992). Due to the high
water solubility of methanol, the distribution of absorbed meth-
anol in the tissues of the body is a function of their relative
water content (Sejersted et al., 1983). Animal studies have
reported that systemic methanol is eliminated mainly by me-
tabolism (70 to 97% of absorbed dose) and only a small
fraction is eliminated as unchanged methanol in urine and in
the expired air (, 3–4%) (Dorman et al., 1994; Horton et al.,
1992).
Systemic methanol is extensively metabolized by liver alco-
hol dehydrogenase and catalase-peroxidase enzymes to form-
aldehyde, which is in turn rapidly oxidized to formic acid by
formaldehyde dehydrogenase enzymes (Goodman and Tephly,
1968; Heck et al., 1983; Røe, 1982; Tephly and McMartin,
1984). Under physiological conditions, formic acid dissociates
to formate and hydrogen ions. Current evidence indicates that,
in rodents, methanol is converted mainly by the catalase-
peroxidase system whereas monkeys and humans metabolize
methanol mainly through the alcohol dehydrogenase system
(Goodman and Tephly, 1968; Tephly and McMartin, 1984).
Formaldehyde, as it is highly reactive, forms relatively stable
adducts with cellular constituents (Heck et al., 1983; Røe,
1982). It can also enter, directly or after oxidation to formate,
the tetrahydrofolic-acid-dependent one-carbon pathway to be-
come the building block of many synthetic pathways (Røe,
1982; Tephly and McMartin, 1984).
The detoxification of formate occurs mainly by a tetrahy-
drofolate-dependent multistep pathway to carbon dioxide
(CO2) (McMartin et al., 1977; Palese and Tephly, 1975). A
small percentage of body formate is also eliminated directly in
the urine (Dorman et al., 1994; Horton et al., 1992). Marked
species differences in methanol toxicity and metabolism have
been reported. Primates and humans appear to be more sus-
ceptible to the acute toxicity of methanol than rodents (Tephly
and McMartin, 1984). This has been mainly attributed to the
slower metabolism and elimination rate of formate in larger
species (Tephly and McMartin, 1984).
Based on the available toxicokinetic data of methanol in rats,
mice, monkeys, and humans, toxicokinetic processes were
described in the past using classic 1 to 3 compartmental models
with saturable elimination (Batterman et al., 1998; Damian and
Raabe, 1996; Dorman et al., 1994; Nihle´n and Droz, 2000;
Pollack and Brouwer, 1996; Pollack et al., 1993; Ward et al.,
1995; Ward and Pollack, 1996). Physiologically based phar-
macokinetic (PBPK) models for methanol in animals and hu-
mans were also developed (Fisher et al., 2000; Horton et al.,
1992; Perkins et al., 1995; Ward et al., 1997).
Recently, a different type of multicompartment modeling
approach has been developed to describe the disposition kinet-
ics of polychlorinated dibenzo-dioxins and furans (PCDD and
PCDFs) (Carrier et al., 1995a,b), azinphosmethyl and its al-
kylphosphate metabolites (Carrier and Brunet, 1999), and
methyl mercury and its inorganic metabolites (Carrier et al.,
2001a,b). This type of biologically based dynamic model is a
refinement of classic compartment models, but is closer to
biological processes and enables simulations for a variety of
exposure scenarios in different species. This heuristic approach
allows essential characteristics of intercompartmental transfer
processes to be captured using a minimum of parameters and
without the need for extensive knowledge of all the physio-
logical processes. The ultimate goal of this approach is to
develop a robust human toxicokinetic model based on human
data, thus avoiding as much as possible uncertainties associ-
ated with animal to human extrapolations.
The objective of the present study was to develop and
validate such a biologically based dynamic model to describe
the time evolution of methanol and its metabolites in the whole
body, and in accessible biological matrices (blood, urine, and
expired air), and allow links to be made between the different
compartments. This model is constructed by establishing the
overall biological determinants of methanol disposition in an-
imals and humans, taking into account the different time-scales
involved in the biological processes. The model parameters
specific to the species of interest are then determined from
direct fits to the in vivo time course data of methanol and its
metabolites in blood and excreta (urine and expired air), avail-
able in the published literature.
METHOD AND MODEL PRESENTATION
Model Development
A toxicokinetic, biologically based, dynamic model was developed to de-
scribe the time evolution of methanol biodisposition in the animal (rat and
monkey) and human body. The modeling process can be described in four
steps: (1) the conceptual and functional representation of the model, (2) the
determination of parameters, (3) the simulation of the kinetic profile, and (4)
the validation of the model.
Conceptual and functional representation. The disposition kinetics of
methanol and its metabolites following exposure to methanol was modeled
using a multicompartment dynamic system, described mathematically by a
system of coupled differential equations. The model conceptual and functional
representation is depicted in Figure 1. It aims to be sufficiently detailed to
describe the available in vivo data provided by Horton et al. (1992) on the
disposition kinetics of methanol and its metabolites in rats. It was then verified
that it described equally well the monkey and human kinetic behavior (Dorman
et al., 1994; Osterloh et al., 1996; Sedivec et al., 1981).
The whole body (blood and tissues) and the excretory routes (urine and
exhaled air) were each represented by a compartment. The whole body loads
of methanol, formaldehyde, formate, and unobserved by-products of formal-
dehyde metabolism were followed. Since methanol distributes quite evenly in
the total body water, detailed compartmental representation of body tissue
loads was not deemed necessary. Formaldehyde in the whole body was also
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represented as a separate compartment although its metabolism rate is too rapid
to allow its quantification (half-life of about 1.5 min according to McMartin et
al. [1979] and Tephly and McMartin [1984]). It can be shown that, under such
fast breakdown, only formaldehyde partitioning between formate and other
by-products is relevant to the unfolding of the dynamics.
The respiratory tract was further represented as a separate compartment
since it is the route of entry of inhaled methanol. Excretion compartments were
the methanol in the exhaled air, the urinary methanol, the urinary formic acid,
the CO2 in the exhaled air, and the excreted unobserved metabolites.
The dynamic of intercompartment exchanges was then described mathemat-
ically by a mass balance differential equation system (see Appendix). Essen-
tially, the rates of change in the amounts of methanol and its metabolites in a
given compartment were described as the difference between compartment
rates of uptake and loss. (Symbols used in the functional representation of the
model are presented in Table 1.) Solving numerically the system of differential
equations yielded the time courses of methanol and its metabolites in the
different compartments.
It should also be mentioned that metabolism was considered to follow
Michaelis-Menten kinetics. However, only in the case of methanol metabolism
to formaldehyde was a saturation constant introduced since, with the exposure
dose range used in the studies on which the model is based, no saturation of
formate or CO2 metabolism was apparent (Dorman et al., 1994; Horton et al.,
1992; Osterloh et al., 1996 Sedivec et al., 1981).
Determination of the parameters. Unknown parameters were estimated
individually from a statistical best-fit to the experimental data specific to the
species of interest, by using the explicit solutions of subsystems of differential
equations when possible (see Appendix). A professional edition of a MathCad
software was used for this purpose (MathSoft Inc., Cambridge, MA).
Rat parameters. Parameters to be determined were the intercompartment
transfer rate coefficients and metabolism rate constants. Data of Horton et al.
(1992) in male Fischer-344 rats exposed to a single iv dose of 100 mg per kg
of body weight of 14C-methanol (n 5 4) were used to determine the rat
parameters. Blood concentration-time profiles (expressed in mg/l) and cumu-
lative urinary excretion time courses of 14C-methanol and 14C-formate (ex-
pressed in mmol) were determined by these authors as well as the cumulative
exhalation time courses of 14C-methanol and 14CO2 (expressed in mmol).
In the current study, for the fitting of experimental data and to determine
parameters, all the experimental values were converted to burdens expressed in
moles. It was then verified that the mass balance was maintained at all time
points. Also, reported blood concentration values were converted to whole
body burdens by multiplication by the apparent volume of distribution (Vd). In
rats, the apparent volume of distribution of methanol (VdMeOH) was determined
so that the initial experimental concentration of methanol in blood at time t 5
5 min, when converted in terms of burden, gives the iv dose (700 mmol)
reported by Horton et al. (1992).
Monkey parameters. To adapt the model to monkey data, only the values
of the intercompartment transfer rates and metabolism constants needed to be
modified. Using the same approach as in rats, transfer parameters values of the
general model solutions were estimated individually by best-fits, using Math-
Cad, to the available experimental data of Dorman et al. (1994). These authors
exposed 4 adult female cynomolgus monkeys (Macaca fascicularis, 3–5.5 kg)
by inhalation to 900 ppm of 14C-methanol for 2 h. Blood concentration-time
profiles of 14C-methanol and 14C-formate (expressed in mmol/l) were deter-
mined as well as the cumulative urinary excretion of 14C-methanol and 14C-
formate 48-h postexposure (expressed in mmol). The time courses of 14C-
methanol and 14CO2 exhalation rates (mmol/min) were also established. For the
determination of the parameter values, the latter rates were converted to
cumulative excretion.
The pulmonary ventilation rate of female cynomolgus monkeys used in the
model was that reported by Dorman et al. (1994), that is on average 33 l/h or
0.56 l/min (equivalent to 0.033 m3/h or 0.8 m3/day).
In monkeys, the apparent volume of distribution of methanol was calculated
by best-fit of the following equation to the data observed during the constant
inhalation built up of methanol blood concentration (B(t)):
VdMeOH(liter) 5
Dexp~mmol/min! 3 fabs
ke lim~min21! 3 B(t)(mmol/liter) 3 ~1 2 e
2ke lim3t!
where kelim is the sum of all rates of methanol elimination (metabolism,
exhalation, and urinary excretion).
Human parameters. When possible, the constants were determined using
the available human data. This includes the pulmonary absorption fraction of
methanol, the pulmonary ventilation rate, the apparent volume of distribution
of methanol, the metabolism rate constant kmet of whole body methanol to
formaldehyde, and the transfer rate constant km of whole body methanol to
urine. The other constant parameters were left as determined in monkeys,
which are considered as good surrogates to humans for the study of methanol
kinetics.
Pulmonary absorption fraction of methanol used in the model adapted to
humans was that reported by Sedivec et al. (1981). The human value was
nonetheless close to that determined in rats and monkeys. Human pulmonary
ventilation rate used in the model was that reported by Sedivec et al. (1981),
that is on average 10.8 l/min. The apparent volume of distribution of methanol
was that reported in the literature, hence, corresponds to the volume of human
body fluids (liters), expressed per kilogram of body weight. This value is about
the same as that determined using the experimental monkey data.
The constant parameter kmet was determined from a best-fit to the blood
concentration-time profile of methanol in human volunteers exposed to 200
ppm of methanol vapors for 4 h, as determined by Osterloh et al. (1996). The
km value was determined by adjustment to the data of Sedivec et al. (1981) on
the urinary excretion time course curves of methanol in volunteers during and
following an 8-h inhalation exposure to 300 mg/m3 of methanol vapors.
FIG. 1. Conceptual representation of methanol kinetics. Symbols are
described in Table 1.
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The experimental data of Sedivec et al. (1981) on the time evolution of
urinary methanol concentrations were converted to cumulative urinary excre-
tion of methanol (in mmol) by considering an average time-dependent fraction
of a daily urinary excretion of 1.5 l (Knuiman et al., 1986).
Model simulation. Once the parameters were determined individually by
statistical fits to the experimental data, mathematical resolution of the complete
model, as represented by the system of differential equations, was performed
by the numerical Runge-Kutta method. Model resolution and simulations were
also conducted using Mathcad software. This allows prediction of the time
evolution of methanol and its metabolites in the different model compartments.
In the model, the exposure dose was converted in mmoles for both the iv and
inhalation exposures. Thus, whole body burdens and amounts excreted in urine
and in the exhaled air are first expressed in mmoles.
In order to simulate the blood concentrations of methanol or formate as a
function of time, the amounts in the whole body predicted by the model were
simply divided by the respective apparent volume of distribution. For rats and
monkeys, the apparent volume of distribution of formate (Vd FA) was estimated
using a conservation of mass equation for formate burden, and by a best-fit to
the observed time course of experimental blood concentration values of for-
mate. For monkeys, this amounts to 6 times the apparent volume of distribution
of methanol. For humans, the same multiple was used.
To simulate the concentration-time profile of methanol in urine, predicted
excretion rates (dM(t)/dt 5 km 3 X(t), expressed in mmol/min) were divided by
the urinary flow rate (l/min). To simulate the concentration-time profile of meth-
anol in the exhaled air, predicted exhalation rates (dE(t)/dt 5 kre 3 L(t) 1 kex 3
X(t), expressed in mmol/min) were divided by the pulmonary ventilation rate
(m3/min).
Simulations of exposure scenarios, where continuous or intermittent doses
are administered through time, were performed by introducing a nonhomog-
enous term, g(t), describing these time varying inputs (see Appendix). Simu-
lations can also be conducted for different routes of exposure (iv, inhalation).
Model Validation
The model developed using the previously mentioned data was validated
using a new set of experimental data. This includes the kinetic time profiles
presented in the inhalation studies of Horton et al. (1992) in rats and monkeys
and Batterman et al. (1998) in human volunteers. Also, some human data of
Sedivec et al. (1981) not used in the development of the model served to
validate the model.
Validation using inhalation data of Horton et al. (1992) in rats. The
model developed using the iv data of Horton et al. (1992) in rats was validated
with the inhalation data of the same authors, on the blood concentration-time
profile of methanol during and following 6-h inhalation exposures to 200,
1200, and 2000 ppm of methanol in male Fischer-344 rats (n 5 4 per group).
For those simulations, the average pulmonary ventilation rate used was 40
ml/min (equivalent to 0.0021 m3/h or 0.051 m3/day) for the 200 ppm dose, 40
ml/min (equivalent to 0.0024 m3/h or 0.058 m3/day) for the 1200 ppm dose,
and 60 ml/min (equivalent to 0.0033 m3/h or 0.080 m3/day) for the 2000 ppm
dose to obtain the best-fit to the experimental data as compared to the average
TABLE 1
Symbols Used in the Conceptual and Functional Representation of the Model
Symbol Description
Variables
g(t) Pulmonary dose per unit of time that can describe time varying inputs
L(t) Burden of methanol in the respiratory tract as a function of time
E(t) Cumulative burden of methanol in the exhaled air as a function of time
X(t) Whole body burden of methanol as a function of time
Y(t) Whole body burden of formaldehyde as a function of time
Z(t) Whole body burden of formate as a function of time
U(t) Unobserved formaldehyde by-products in the body and excreta as a function of time
O(t) Whole body burden of unobserved formaldehyde by-products as a function of time
N(t) Cumulative burden of unobserved formaldehyde by-products in excreta as a function of time
M(t) Cumulative burden of methanol in urine as a function of time
F(t) Cumulative burden of formic acid in urine as a function of time
C(t) Cumulative burden of CO2 in the exhaled air as a function of time
h(X(t)) The Michaelis-Menten saturation function
Constants
fabs Pulmonary absorption fraction of methanol
kabs Pulmonary absorption rate constant of methanol
kre Exhalation rate constant of unabsorbed methanol
kex Exhalation rate constant of absorbed methanol
kmet Metabolism rate constant of methanol to formaldehyde
Km Michaelis-Menten affinity constant for methanol metabolism
kfald Metabolism rate constant of formaldehyde
kform Metabolism rate constant of formaldehyde to formate
koth Metabolism rate constant of formaldehyde to unobserved metabolites
kn Whole body to excreta transfer coefficient of unobserved formaldehyde by-products
kCO2 Whole body to exhaled air transfer coefficient combined with metabolism rate constant of formate to CO2
km Whole body to urine transfer coefficient of methanol
ku Whole body to urine transfer coefficient of formate
VdMeOH Apparent volume of distribution of methanol
VdFA Apparent volume of distribution of formate
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value of 3.04 l/h or 50 ml/min (equivalent to 0.0030 m3/h or 0.073 m3/day)
reported by Horton et al. (1992).
Validation using inhalation data of Horton et al. (1992) in monkeys. The
model adapted to the monkey data of Dorman et al. (1996) was validated using
the data of Horton et al. (1992) on the blood concentration-time profile of
methanol in 3 young adult male rhesus monkeys (Macaca mulatta, 5–7 kg)
exposed to methanol vapor concentrations of 200, 1200, or 2000 ppm for 6 h.
For these simulations, the average pulmonary ventilation rate was that reported
by Horton et al. (1992), that is 48.9 l/h or 0.81 l/min (equivalent to 0.049 m3/h
or 1.2 m3/day).
Validation using inhalation data of Sedivec et al. (1981) and Batterman et
al. (1998) in humans. The data of Sedivec et al. (1981) on the urinary
excretion time course curves of methanol in volunteers during and following
8-h inhalation exposures to 102 and 205 mg/m3 of methanol vapors were used
in the validation process of the model for humans.
The model adapted to human data was also validated using the data of
Batterman et al. (1998) on the time-dependent disposition of methanol in
blood, urine, and breath of volunteers exposed to methanol vapor concentration
of 800 ppm for periods of 0.5, 1, and 2 h.
Batterman et al. (1998) presented their data as urinary and exhaled concen-
tration-time profiles (expressed in mg/l and ppm, respectively). Although in
this article the time courses of methanol cumulative excretion in urine and
exhaled air are usually presented to insure mass balance conservation, it was
also verified that the model gave a good prediction of the overall concentra-
tion-time profiles of methanol in urine and exhaled air (data not shown). To
obtain a good fit on both the concentration values and cumulative burdens, a
time-dependent fraction of a daily urinary excretion of 2.4 l for the 30 min and
2 h exposures and of 2.7 l for the 1 h exposure had to be considered. It has been
reported that the daily personal urine volume may commonly vary from 0.6 l
to more than 2.5 l (Knuiman et al., 1986). The average pulmonary ventilation
rate used was 11.3, 8.4, and 10.8 l/min for the 30 min, 1 h, and 2 h exposures,
respectively, to obtain a best-fit to the exhalation data. These latter rates are in
the value range reported by Sedivec et al. (1981; average [range]: 10.8
[8.4–13.8] l/min).
RESULTS
Model Developed Using the IV Data of Horton et al. (1992)
in Male Fischer-344 Rats
Table 2 presents the rat parameter values of the model
determined using the data of Horton et al. (1992) in male
Fischer rats exposed via iv to 100 mg of 14C-labeled methanol
per kg of body weight (see Table 1 for the description of
symbols). Figures 2 and 3 show that these parameter values
allowed to reproduce closely the data presented by Horton et
al. (1992) on the time courses of blood concentrations of
methanol and formate as well as on the cumulative urinary
excretion of methanol and formate and the cumulative exhala-
tion of methanol and CO2.
The estimated average Michaelis-Menten affinity constant
value reported in Table 2 and determined using the iv data
(Km-IV of 770 mmol, which represents the body burden of
methanol corresponding to half of the maximal velocity for
methanol metabolism) shows that when injecting 100 mg/kg of
14C-methanol to Fischer rats (700 mmol), metabolism is not yet
saturated. From the product of Km-IV and kmet, an average Vmax
value of 411 mmol/h can be calculated.
The model predicts that methanol elimination from the
whole body is quite rapid (mean elimination half-life of 1.3 h)
and that, on average, only 0.01% of methanol remains in the
unchanged form 18 h following iv injection of 100 mg/kg of
14C-methanol in rats. Peak levels of free formaldehyde in the
whole body are reached 0.5 h postdosing, at which time form-
aldehyde burden represents on average 3.2% of the injected
dose. Virtually no free formaldehyde remains in the body 18 h
postexposure. The metabolism of methanol to formaldehyde
(kmet) is predicted to be the rate limiting step in the whole body
elimination kinetics of free formaldehyde. Indeed, the biotrans-
formation of formaldehyde to its by-products is estimated to be
very rapid (kform 1 koth being very large) compared to methanol
metabolism to formaldehyde (kmet), as apparent when compar-
ing reports of McMartin et al. (1979) and Horton et al. (1992).
On the other hand, according to model predictions, peak
levels of unbound formate in the whole body are reached only
3–3.5 h postexposure where average formate burden represents
TABLE 2
Numerical Values of Constant Parameters Used in the Model
Adjusted to Male Fischer-344 rat, Female Cynomolgus Monkey,
and Human Data
Constant parameter Rat value Monkey value Human value
Absorption fraction
fabs 0.60 0.69 0.577a
Transfer rate
kmet 0.53 0.96b 0.4
kform 14.6 7.2 7.2
koth 13.0 20.4 20.4
kex 9.3 3 10–3 5.1 3 10–3 5.1 3 10–3
kCO2 318.6 3 10–3 813.4 3 10–3 813.4 3 10–3
km 3.1 3 10–3 242.1 3 10–6 2.0 3 10–3





VdMeOH 0.92 0.77 0.70
VdFA 6.4 4.6 4.2
Note. Rat values were determined using the experimental Fischer-344 rat
data of Horton et al. (1992). Monkey values were determined using the
experimental female cynomolgus monkey data of Dorman et al. (1994).
Human values were kept as in monkeys except for fabs, which is similar to that
determined by Sedivec et al. (1981); kmet was adjusted to the human blood
concentration-time profile of methanol of Osterloh et al. (1996) and km was
determined using the human urinary time course data of methanol of Sedivec
et al. (1981). Transfer rate is given in h–1, saturation constant given in mmol,
volume of distribution given as l/kg of body weight.
aUsed for the simulation of Osterloh et al. (1996) and Sedivec et al. (1981)
studies. For the simulation of the data of Batterman et al. (1998), a value
ranging from 0.76 to 0.81 was deemed more appropriate, which is in agreement
with the mean value of 0.79 reported by those authors.
bUsed to fit to the female cynomolgus monkey data of Dorman et al. (1994).
To adapt the model to the data of Horton et al. (1992) in male rhesus monkeys,
kmet value was estimated to be 0.22/h.
cDetermined using the iv data of Horton et al. (1992).
dDetermined using the inhalation data of Horton et al. (1992).
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20.1% of injected 14C-methanol. Eighteen h postexposure, on
average 0.5% of the dose remains in the body as free formate.
Initial build-up of unbound formate in the body prior to attri-
tion is dependent on the fact that the metabolism rate constant
of formaldehyde to formate (kform) is very rapid (average half-
life of about 10 min) compared to the major elimination route
of formate, the metabolism rate to CO2 and subsequent exha-
lation (kCO2), for which a mean half-life of 2.2 h can be
calculated. Since the urinary excretion of formate is negligible
compared to CO2 exhalation, the former contributes only mar-
ginally to the whole body time course of formate.
In fact, the model predicts that on average 48.8% of the
14C-methanol iv dose is eliminated as exhaled CO2 as com-
pared to 1.7% as urinary formate, which is congruent with the
experimental results of Horton et al. (1992). In comparison, it
is estimated from the model that on average 0.8% of the dose
is excreted as unchanged methanol in the urine and 2.4% of
body methanol is exhaled unchanged again in accordance with
the experimental data of Horton et al. (1992).
Model Validation Using the Inhalation Data of Horton et al.
(1992) in Fischer-344 Rats
With the parameter values determined using the iv data of
Horton et al. (1992), the model was applied to another set of
data from the same authors on the blood concentration-time
profiles of methanol during and following 6-h inhalation ex-
posures to 200, 1200, and 2000 ppm of methanol in male
Fischer-344 rats. It gave a good prediction of the time-course
curves for the 2 lowest doses but underestimated the blood
concentrations for the 2000 ppm dose (data not shown).
Thus, a new value of the saturation constant Km was esti-
mated from a statistical best-fit on the blood concentration-time
profile data of Horton et al. (1992) in male Fischer-344 rats
exposed by inhalation to 2000 ppm of methanol vapors for 6 h
(Km-Inh) (see Table 2). This Km-Inh value was about 3 times
smaller than that determined with the iv data (on average 235
mmol). Thus, after inhalation exposure to 2000 ppm, saturation
of methanol metabolism appears to occur at a lower body
burden. With this Km-Inh value, a Vmax of 125 mmol/h was
calculated. Using this newly determined Km constant for an
FIG. 3. (A) Model simulations (lines) compared with experimental data
of Horton et al. (1992) on the cumulative urinary excretion profiles of
methanol (crossbars) and formate (circles) over 18 h following a single iv
dose of 100 mg/kg of 14C-labeled methanol in male Fischer-344 rats. Each
point represents mean value of experimental data (n 5 4). (B) Model
simulations (lines) compared with experimental data of Horton et al. (1992)
on the cumulative exhalation profiles of methanol (crossbars) and CO2
(squares) over 18 h following a single iv dose of 100 mg/kg of 14C-labeled
methanol in male Fischer-344 rats. Each point represents mean value of
experimental data (n 5 4).
FIG. 2. Model simulations (lines) compared with experimental data of
Horton et al. (1992) on the concentration-time courses of methanol (crossbars)
and formate (circles) in blood over 10 h following a single iv dose of 100
mg/kg of 14C-labeled methanol in male Fischer-344 rats. Each point represents
mean value of experimental data (n 5 4).
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inhalation exposure, the proposed model provided a close
approximation to the data of Horton et al. (1992) on the blood
concentration-time profiles of methanol in male Fischer-344
rats exposed to vapor concentrations of 200, 1200, and 2000
ppm of methanol for 6 h (Fig. 4).
Model Adapted to Female Cynomolgus Monkey Data
of Dorman et al. (1994)
Using the conceptual and functional representation of the
model established with rat data, the model was adapted to
monkeys by adjusting parameters values (see Table 2), through
a statistical best-fit, to the data of Dorman et al. (1994) in
female cynomolgus monkeys exposed by inhalation to metha-
nol vapors. As observed in rats, pulmonary absorption of
methanol was estimated to be very rapid (a few minutes) as
compared to the metabolism rate constant kmet of whole body
methanol to formaldehyde. The predicted pulmonary absorp-
tion fraction of methanol in monkeys was in the same range as
that determined in rats. The estimated monkey constant kmet
was however 1.8 times higher than in rats. Interestingly, con-
trary to the rat, according to the data of Dorman et al. (1994),
no saturation of methanol metabolism was apparent in mon-
keys even after a 2-h inhalation exposure to 2000 ppm.
Further comparison of monkey and rat parameter values
shows that the estimated monkey metabolism rate constant kform
of whole body formaldehyde to formate was 2.0 times lower
than that of rats. This was also the case for exhalation rate
constant kex of absorbed methanol (1.8 times). The monkey
kCO2 value, which represents a combined metabolism rate con-
stant of whole body formate to CO2 and transfer rate constant
of CO2 to the exhaled air, was estimated to be 2.6 times higher
than in rats. As observed with the rat data of Horton et al.
(1992), no saturation of formaldehyde or formate metabolism
was apparent from the data of Dorman et al. (1994).
It is also noteworthy that the estimated monkey transfer rate
constant ku of whole body formate to urine was 5.4 times lower
than in rats and the monkey transfer rate constant km of whole
body methanol to urine was 12.8 times smaller than that
obtained for rats. The estimated monkey apparent volume of
distribution of methanol and formate, expressed in liters per
kilogram of body weight, were only slightly lower than those
of the rats (1.2 and 1.4 times, respectively).
With the parameter values described in Table 2, Figure 5
shows that the model provides a close approximation to the
data obtained by Dorman et al. (1994) on the blood concen-
tration-time profiles of methanol and formate as well as the
time dependent variations in methanol and CO2 exhalation
rates over the 8-h period following the beginning of a 2-h
inhalation exposure to 900 ppm of 14C-methanol in adult fe-
male cynomolgus monkeys. Although the corresponding de-
tailed urinary excretion profiles of methanol and formate were
not depicted by Dorman et al. (1994), cumulative excretion of
methanol and formate in urine was reported. The model suc-
ceeded in reproducing closely these values (0.43 mmol pre-
dicted as compared to 0.41 mmol observed on average for
urinary methanol, and 1.12 mmol predicted as compared to
1.15 mmol observed on average for urinary formate).
Model Validation Using the Inhalation Data of Male Rhesus
Monkeys of Horton et al. (1992)
The model, with parameter values adapted as above to
cynomolgus monkey data of Dorman et al. (1994), was further
validated using experimental results of Horton et al. (1992) in
young male rhesus monkeys exposed for 6 h to vapor concen-
trations of 1200 and 2000 ppm (These authors also exposed
monkeys to 200 ppm but concentration values were too small
to provide an accurate prediction.) It was assumed that differ-
ences in the kinetics were mainly a result of interstrain differ-
ences in the metabolism rate of methanol, kmet. With a smaller
average kmet value of 0.22/h determined by statistical best-fit
for larger male rhesus monkeys (5–7 kg) as compared to 0.96/h
for smaller female cynomolgus monkeys (3.5–5 kg), the model
was able to reproduce the concentration-time course data of
methanol in blood of Horton et al. (1992) as seen in Figure 6.
It is also interesting to note that, as reported by Horton et al.
(1992), the model predicts that blood formate concentrations in
monkeys will not exceed endogenous background values even
for 6-h inhalation exposures to 2000 ppm of methanol vapors
(data not shown). This was also observed when simulating the
data of Dorman et al. (1994) on the blood concentration-time
course curve of formate in monkeys exposed to 900 ppm of
methanol vapors for 2 h.
FIG. 4. Model simulations (lines) compared with experimental data of
Horton et al. (1992) on the time courses of methanol concentrations in blood
during and following 6-h inhalation exposures to 200 (diamonds), 1200 (cross-
bars), and 2000 (squares) ppm of methanol vapors in male Fischer-344 rats.
Each point represents mean value of experimental data (n 5 4).
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Model Adapted to the Human Data of Osterloh et al. (1996)
and Sedivec et al. (1981)
The parameter values estimated by fitting the model to the
observed data of Osterloh et al. (1996) and Sedivec et al.
(1981) on the disposition of methanol and its metabolites in
humans are presented in Table 2. The estimated value of kmet
was in the same range as that determined in animals. The km
value was estimated to be close to that obtained in rats (1.5
times lower) but 8.3 times higher than that of monkeys.
Figure 7 shows that the model simulates correctly the data
obtained by Osterloh et al. (1996) on the concentration-time
course of blood methanol in human volunteers exposed by
inhalation to 200 ppm of methanol for 4 h. The model included
a constant background whole body methanol burden of 2133
mmol, which corresponds to the mean blood concentration of
1.5 mg/l of methanol measured by Osterloh et al. (1996) in
control subjects at the end of an 8-h frequent blood sampling
FIG. 5. (A) Model simulations (lines) compared with experimental data of
Dorman et al. (1994) on the time courses of methanol (crossbars) and formate
(circles) concentrations in blood during and following a 2-h inhalation expo-
sure to 900 ppm of 14C-methanol in adult female cynomolgus monkeys
(Macaca fascicularis). Each point represents mean value of experimental data
(n 5 4). (B) Model simulations (lines) compared with experimental data of
Dorman et al. (1994) on the time courses of methanol (crossbars) and CO2
(squares) exhalation rates during and following a 2-h inhalation exposure to
900 ppm of 14C-methanol in adult female cynomolgus monkeys. Each point
represents mean value of experimental data (n 5 4).
FIG. 6. Model simulations (lines) compared with experimental data of
Horton et al. (1992) on the time courses of methanol concentrations in blood
following 6-h inhalation exposures to 1200 (crossbars) and 2000 (circles) ppm
of methanol vapors in young male rhesus monkeys (Macaca mulatta). Each
point represents mean value of experimental data (n 5 3).
FIG. 7. Model simulations (solid lines) compared with experimental data of
Osterloh et al. (1996) on the blood concentration-time profile of methanol in
human volunteers during and following a 4-h inhalation exposure to 200 ppm of
methanol vapors (crossbars). Background blood methanol concentration values
considered for model simulations (dashed lines) and experimentally determined by
Osterloh et al. (1996) over the course of their experimental study (circles) are also
represented. Symbols represent mean experimental values from 22 subjects.
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period. In accordance with the experimental data of Osterloh et
al. (1996), the model predicts a log-linear elimination of blood
methanol over the 4-h sampling period following exposure
(data not shown), indicating the absence of saturation of meth-
anol metabolism for the 4-h inhalation exposure at 200 ppm.
Figure 8 compares model simulations to the time dependent
cumulative excretion of methanol in human volunteers during
and following 8-h inhalation exposures to 102, 205, and 300
mg/m3, as determined from the data of Sedivec et al. (1981). A
mean background whole body burden of methanol of 700 to
1000 mmol depending on the dose (equivalent to a blood
concentration of 0.4–0.6 mg/l) was included in the model,
which gives predicted baseline urinary concentrations in the
same value range as those experimentally observed (0.7 mg/l
on average). With these initial conditions, predictions were in
close agreement with the experimentally observed data.
Model Validation Using the Inhalation Data of Batterman
et al. (1998) in Human Volunteers
The model adapted to humans was applied to the data of
Batterman et al. (1998) in human volunteers exposed to methanol
vapor concentrations of 800 ppm for 30 min, 1 h, and 2 h. All the
parameter values were kept as determined with the previous
human data of Osterloh et al. (1996) and Sedivec et al. (1981)
except for the pulmonary retention. Indeed, for a proper simula-
tion of the experimental data, the average pulmonary absorption
fraction had to be 0.76, 0.82, and 0.81 for the 30 min, 1, and 2 h
exposures, respectively, which is congruent with the mean value
of 0.79 reported by Batterman et al. (1998). With these values,
Figures 9–11 show that simulations were in close agreement with
the experimentally determined concentration-time profiles of
methanol in blood, as well as the time evolution of methanol
cumulative excretion in urine and in the exhaled air for the various
exposure scenarios. A good fit was obtained even when neglecting
background methanol in the whole body. Regarding Figure 11,
the exhalation rate is almost constant during the exposure, which
explains the plateau for the cumulative exhalation.
Prediction of the Time Course Curves of Methanol and
Formate Concentrations in Blood and Urine during
a 5-Day Continuous Exposure to Methanol Vapor
Concentrations of 200 ppm in Humans
The model can also be used to predict the time-dependent
variations of methanol and formate concentrations in human
FIG. 9. Comparison of model simulations (lines) with experimental data
(symbols represent mean values from 4 subjects) of Batterman et al. (1998) on
the blood concentration-time profiles of methanol in 3 groups of human
volunteers during and following inhalation exposures to 800 ppm of methanol
vapors for 30 min (A), 1 h (B), and 2 h (C).
FIG. 8. Model simulations (lines) compared with experimental data of
Sedivec et al. (1981) on the cumulative urinary excretion time-course of
methanol in human volunteers during and following 8-h inhalation exposures
to 102 (diamonds), 205 (crossbars), and 300 (squares) mg/m3 of methanol.
Symbols represent mean experimental values from 4 subjects.
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blood and urine during a continuous inhalation exposure to 200
ppm of methanol, considering a negligible background burden
of methanol, an absorption fraction of 0.577, a pulmonary
ventilation rate of 10.8 l/min, and a daily urinary excretion rate
of 1.5 l. Near steady state levels were reached within 20 h
following the start of exposure. At the end of a 5-day exposure
period, predicted blood concentration of methanol was 5.5 mg/l
(171 mmol/l) and that of formate was 0.16 mg/l (3.5 mmol/l).
The latter formate concentration was obtained by considering
an apparent volume of distribution of formate in humans (in
l/kg of body weight) similar to that calculated for monkeys.
With this exposure level, the model predicts near steady state
urinary concentrations of methanol of 8.1 mg/l (252 mmol/l)
and of formic acid of 1.5 mg/l (31.7 mmol/l, 0.97 mg/g creat-
inine, or 2390 mmol/mol creatinine).
Thus, at the end of a 5-day continuous inhalation exposure to
200 ppm of methanol vapors, predicted methanol concentra-
tions in blood and urine were 5 to 11 times greater than
reported mean background values of unexposed subjects (1
mg/l in blood and 0.73 mg/l in urine) (Osterloh et al., 1996;
Sedivec et al., 1981). On the other hand, predicted concentra-
tions of blood formate and urinary formic acid in humans (0.16
and 1.5 mg/l, respectively), although in accordance with the
experimental data from methanol exposures in primates and
humans, were well below mean background values of unex-
posed subjects (4.9–10.3 mg/l in blood and 6.3–13 mg/l in
FIG. 11. Comparison of model simulations (lines) with experimental data
(symbols represent mean values from 4 subjects) of Batterman et al. (1998) on
the cumulative exhalation time courses of methanol in 3 groups of human
volunteers during and following inhalation exposures to 800 ppm of methanol
vapors for 30 min (A), 1 h (B), and 2 h (C).
FIG. 10. Comparison of model simulations (lines) with experimental data
(symbols represent mean values from 4 subjects) of Batterman et al. (1998) on
the cumulative urinary excretion time courses of methanol in 3 groups of
human volunteers during and following inhalation exposures to 800 ppm of
methanol vapors for 30 min (A), 1 h (B), and 2 h (C).
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urine) reported by various authors (Baumann and Angerer,
1979; D’Alessandro et al., 1994; Heinrich and Angerer, 1982;
Lee et al., 1992; Osterloh et al., 1996).
The model simulations suggest that an 8-h inhalation expo-
sure of at least 500 to 2000 ppm, without physical activities,
would be necessary for blood formate and urinary formic acid
concentrations to reach reported mean background values. The
exact exposure levels necessary depend on the values assumed
for the absorption fraction, the pulmonary ventilation rate, and
the daily urinary excretion rate. There are considerable varia-
tions in the literature for these parameters.
DISCUSSION
Model Description of the Kinetics of Methanol and
Its Metabolites
A biologically based dynamic model was developed to sim-
ulate the uptake and disposition of methanol and its metabolites
(formaldehyde, formate, CO2) in animals and humans. Based
on the in vivo time profiles of methanol, formate, and CO2 in
blood and accessible biological matrices, the model was able to
reproduce the essential kinetic processes of methanol disposi-
tion. It can now be used to quantitatively relate the parent
compound or the metabolites in biological matrices to the
absorbed dose and tissue burdens at any point in time in rats,
monkeys, and humans for different exposure situations, thus
reducing the uncertainties in the dose-response relationship,
animal-to-human, and exposure scenario comparisons.
The model showed that the kinetics of systemic methanol
were dependent on the pulmonary uptake and on the metabo-
lism of methanol to formaldehyde. The pulmonary absorption
fraction and ventilation rate were the only model parameters
that needed to be modified within a species to provide a good
prediction of all the data sets. These predicted parameters were,
however, in the value range reported in the published literature
(Dorman et al., 1994; Fisher et al., 2000; Horton et al., 1992;
Sedivec et al., 1981). The pulmonary absorption fraction did
not appear to be influenced by the exposure level or duration
nor by the pulmonary ventilation rate, as observed previously
by Sedivec et al. (1981) and Medinsky et al. (1997).
For all the other parameters, a single set of values for a given
species and strain was found to provide a close approximation
to the available kinetic time profile data. In particular, a single
average value for the metabolism rate constants can be used in
the model for a given exposure route. In accordance with the
published animal data (Dorman et al., 1994; Horton et al.,
1992), the model predicts that absorbed methanol is eliminated
mainly by metabolism to formaldehyde and that only a minor
fraction of the exposure dose is eliminated as unchanged meth-
anol in urine.
On the other hand, from the rat data of Horton et al. (1992),
differences in the saturation of methanol metabolism were
observed depending on the exposure route. Indeed, in the rat
model, a same value for the metabolism rate constant of whole
body methanol to formaldehyde, kmet, was found to provide a
close approximation to the data of Horton et al. (1992) on the
blood concentration-time profiles of methanol after iv and
inhalation exposures to methanol in Fischer-344 rats. However,
the Km value determined using the inhalation data was 3 times
smaller than that obtained using the iv data. Although methanol
has been reported to be metabolized mainly in the liver, pul-
monary metabolism is also likely to occur. Indeed, the catalase-
peroxidase system responsible for a major fraction of methanol
metabolism in rats is widely distributed in mammalian tissues
(Housset, 1986; Morikawa and Harada, 1969; Sugata et al.,
1979). It is, in particular, present in the membranes of the
upper respiratory tract, the main site of pulmonary absorption
of methanol (Perkins et al., 1996). Of course, given that the Km
parameters were estimated from mean blood concentration data
without taking into account interindividual variations, it cannot
be excluded that there is no significant difference between the
2 route-specific Km values.
It should be remembered that, only in the case of methanol
metabolism to formaldehyde was a saturation constant neces-
sary. As mentioned previously, for the exposure dose range of
the studies on which the model is based, no saturation of
formate or CO2 metabolism was apparent (Dorman et al.,
1994; Horton et al., 1992; Osterloh et al., 1996; Sedivec et al.,
1981). Though the saturation of formate metabolism has been
reported after very high iv doses of sodium formate in rats
(164, 328, and 492 mg/kg; Damian and Raabe, 1996) and
appeared to occur in a case of methanol poisoning in a human
subject (Jacobsen et al., 1988), under inhalation exposures
levels in occupational and general environments, it is unlikely
to occur.
According to model predictions, congruent with the data in
the literature (Dorman et al., 1994; Horton et al., 1992), a
certain fraction of formaldehyde is readily oxidized to formate,
a major fraction of which is rapidly converted to CO2 and
exhaled, whereas a small fraction is excreted as formic acid in
urine. However, fits to the available data in rats and monkeys
of Horton et al. (1992) and Dorman et al. (1994) show that,
once formed, a substantial fraction of formaldehyde is con-
verted to unobserved forms. This pathway contributes to a
long-term unobserved compartment. The latter, most plausibly,
represents either the formaldehyde that (directly or after oxi-
dation to formate) binds to various endogenous molecules
(Heck et al., 1983; Røe, 1982) or is incorporated in the tetra-
hydrofolic-acid-dependent one-carbon pathway to become the
building block of a number of synthetic pathways (Røe, 1982;
Tephly and McMartin, 1984). That substantial amounts of
methanol metabolites or by-products are retained for a long
time is verified by Horton et al. (1992) who estimated that 18 h
following an iv injection of 100 mg/kg of 14C-methanol in male
Fischer-344 rats, only 57% of the dose was eliminated from the
body. From the data of Dorman et al. (1994) and Medinsky et
al. (1997), it can further be calculated that 48 h following the
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start of a 2-h inhalation exposure to 900 ppm of 14C-methanol
vapors in female cynomolgus monkeys, only 23% of the ab-
sorbed 14C-methanol was eliminated from the body. These
findings are corroborated by the data of Heck et al. (1983)
showing that 40% of a 14C-formaldehyde inhalation dose re-
mained in the body 70 h postexposure.
In the present study, the model proposed rests on acute
exposure data, where the time profiles of methanol and its
metabolites were determined only over short time periods (a
maximum of 6 h of exposure and a maximum of 48 h postex-
posure). This does not allow observation of the slow release
from the long-term components.
It is to be noted that most of the published studies on the
detailed disposition kinetics of methanol regard controlled
short-term (iv injection or continuous inhalation exposure over
a few hours) methanol exposures in rats, primates, and humans
(Batterman et al., 1998; Damian and Raabe, 1996; Dorman et
al., 1994; Ferry et al., 1980; Fisher et al., 2000; Franzblau et
al., 1995; Horton et al., 1992; Jacobsen et al., 1988; Osterloh
et al., 1996; Pollack et al., 1993; Sedivec et al., 1981; Ward et
al., 1995; Ward and Pollack, 1996). Experimental studies on
the detailed time profiles following controlled repeated expo-
sures to methanol are lacking. Data on methanol and formate
concentrations in spot blood and urine samples of chronically
exposed workers (Baumann and Angerer, 1979; Kawai et al.,
1991; Yasugi et al., 1992) are available but uncertainties re-
garding the exposure dose and concomitant exposure to other
chemicals limit their use in the elaboration of a kinetic model.
With regard to the apparent volume of distribution of meth-
anol, which was calculated in the current study using classic
approaches (see Method and Model Presentation), it was ex-
pected that its value would correspond approximately to the
whole body water content. The slightly larger weight adjusted
volume of distribution of methanol calculated in rats (0.92 l/kg
of body weight) as compared to monkeys (0.77 l/kg of body
weight) can be explained by the smaller adipose tissue fraction
of body weight in rats.
As for the apparent volume of distribution of formate deter-
mined in this study, the weight adjusted values calculated in
rats and monkeys were in the same range, although slightly
higher in rats than in monkeys (6.4 and 4.6 l/kg of body weight,
respectively). However, the volume of distribution of formate
was larger than that of methanol, which strongly suggests that
formate distributes in body constituents other than water, such
as proteins. The closeness of our simulations to the available
experimental data on the time course of formate blood concen-
trations is consistent with the volume of distribution concept
(i.e., rapid exchanges between the nonblood pool of formate
and blood formate).
Species Differences in the Kinetics of Methanol and
Its Metabolites
Critical biological determinants of species differences in the
disposition of methanol and its metabolites were determined
from in vivo data from several studies (Batterman et al., 1998;
Fisher et al., 2000; Horton et al., 1992; Sedivec et al., 1981).
In agreement with their findings, the model predicts that the
average pulmonary absorption fraction fabs of methanol and the
metabolism rate constant kmet of whole body methanol to
formaldehyde were in the same value range in rats, monkeys,
and humans (on average 0.58–0.82 for fabs and 0.219–0.96/h
for kmet). However, the saturation of methanol metabolism
appeared to occur at a lower exposure dose in rats than in
monkeys and humans. Indeed, from the data of Horton et al.
(1992) on the blood concentration-time profile of methanol in
rats exposed to 2000 ppm of methanol vapors for 6 h, a Km
value of 36.6 mg/l of blood and Vmax of 19.4 mg/l/h were
estimated in the current study whereas following a similar
exposure in monkeys, no saturation of methanol metabolism
was apparent. The model also predicts that there is no satura-
tion of methanol metabolism from the data of Batterman et al.
(1998) in human volunteers exposed to 800 ppm of methanol
vapors for 2 h nor from those of Sedivec et al. (1981) in
volunteers exposed to 229 ppm of methanol vapors for 8 h.
Interestingly, a striking species difference in the kinetics was
attributed to a metabolism rate constant ratio kform/kfald of whole
body formaldehyde to formate twice as high in rats than in
monkeys (0.53 vs. 0.26). Thus, in monkeys and plausibly
humans, a much larger fraction of body formaldehyde is rap-
idly converted to unobserved forms rather than passed on to
formate and eventually CO2.
Comparison of the Current Model with Others Previously
Published
The current biologically based dynamic model can be com-
pared to some of the previously published models. In particu-
lar, Horton et al. (1992) developed a PBPK model to describe
the kinetics of methanol and its metabolites in rats, monkeys,
and humans. Their model was comprised of 4 compartments:
liver, kidney, and richly and slowly perfused tissues. As in our
model, the metabolism of methanol to formaldehyde was as-
sumed to be the main biological determinant of methanol
elimination kinetics. In addition, in both the current model and
that published by Horton et al. (1992), not only were the
kinetics of methanol in blood, urine, and exhaled air modeled
but also the time evolution of formate in blood and urine and
of CO2 in the exhaled air. However, in the study of Horton et
al. (1992), 2 saturable metabolic pathways for methanol me-
tabolism were considered whereas in our study, even by intro-
ducing only 1 metabolism route for methanol, with saturable
elimination, the model gave a good prediction of the experi-
mental data. In the PBPK model of Horton et al. (1992), the
metabolism of formate and CO2 was also assumed to follow
Michaelis Menten kinetics. In our model, as mentioned previ-
ously, no saturation constants for these metabolism processes
were introduced since fits to the available time course data
suggested the absence of saturation of formate and CO2 me-
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tabolism in the exposure dose range used in the studies on
which the model is based.
Furthermore, conceptual and functional differences between
the current model and the PBPK model of Horton et al. (1992)
are related to the fact that the current model compartmental-
ization is dependent on the availability of experimental data on
the detailed time course of methanol and its metabolites in
blood, tissues, and excreta and on the hierarchy of the time
scales for the various biological processes. The main structural
difference between our model and that of Horton et al. (1992)
concerns our regrouping into a single compartment the meth-
anol body burden whereas Horton et al. (1992) have frag-
mented the body into several compartments according to the
general PBPK structure. In our model, methanol body burden
regrouping relies on the fact that methanol distributes uni-
formly and rapidly in total body water and thus the apparent
volume of distribution of methanol corresponds to the total
body water content. This allowed us to reduce the number of
parameters to be determined to describe the overall model
dynamics of methanol. Based on the available data on metha-
nol blood kinetics for the 3 species studied, this regrouping
also enabled the determination of species specific parameters
by direct fits, without the need for allometric extrapolation.
Furthermore, the current model ensures conservation of mass
by the introduction of an unobserved metabolite compartment.
In the model of Horton et al. (1992), to account for the fraction
of the methanol dose that was unobserved experimentally and
thus to obtain a good fit to their experimental data on the
cumulative exhalation of CO2 in rats exposed to 14C-labeled
methanol, the rate of formate metabolism had to be multiplied
by 0.6 to correspond to the fraction of the methanol dose
eventually excreted as CO2 over the 18-h sample collection
period of their study.
More recently, Fisher et al. (2000) published a PBPK model
for monkeys to describe the kinetics of methanol. The structure
of their PBPK model for methanol was similar to that of
Horton et al. (1992) but also accounted for the fractional
systemic uptake of inhaled methanol vapors in the lungs. This
fractional systemic uptake was also introduced in our model.
Prediction of the Most Useful Biological Indicator
of Exposure to Methanol
The biological monitoring of exposure, through the analysis
of blood concentrations or urinary and exhaled levels, has
become an increasingly popular means of estimating the ab-
sorbed dose. This model can be used in conjunction with
biological measurements of methanol and formate or formic
acid to determine the level of exposure and subsequent
build-up in tissues. It can also help to establish the best
biomarker of exposure, the sampling strategy for routine mon-
itoring and the significance of measurements at different times.
Since systemic formate is thought to be responsible for a
large part of the deleterious effects induced by methanol
exposures (Tephly and McMartin, 1984), the measurement
of blood formate or urinary formic acid appears interesting
a priori for the biological monitoring of exposure to meth-
anol. However, the model shows that background concen-
trations of formate are much higher than those stemming
from fairly high methanol exposures. Indeed, the model,
adapted to kinetic data in human volunteers exposed acutely
to methanol vapors, predicts that 8-h inhalation exposures
ranging from 500 to 2000 ppm are needed to increase blood
formate concentrations above reported mean endogenous
values of 4.9 to 10.3 mg/l (Baumann and Angerer, 1979; Lee
et al., 1992; Osterloh et al., 1996), and for urinary formic
acid concentrations to reach the published mean background
values of 6.3 to 13 mg/l (Baumann and Angerer, 1979;
D’Alessandro et al., 1994; Heinrich and Angerer, 1982).
The monkey data of Dorman et al. (1994) show that even
after a 2-h inhalation exposure to 900 ppm of 14C-methanol
in female cynomolgus monkeys, 14C-formate concentrations
in blood were far below normal endogenous values. Like-
wise, studies in human volunteers acutely exposed to meth-
anol, at the level of 200 ppm, concur to indicate that blood
formate and urinary formic acid concentrations remain
within the background value range of unexposed subjects
(D’Alessandro et al., 1994; Franzblau et al., 1993; Lee et
al., 1992; Osterloh et al., 1996).
Only in the studies of Kawai et al. (1991) and Yasugi et al.
(1992) was a significant correlation between the urinary excre-
tion of formic acid and exposure to methanol vapors observed.
However, the workers were exposed to airborne concentrations
of methanol of up to 4000 ppm over an 8-h workshift.
These findings suggest that it is not justified to monitor
concentrations of blood formate or urinary formic acid at
methanol exposure levels in the range of or below the airborne
threshold limit value of 200 ppm for occupational settings. If
toxic effects do occur following low level methanol exposures,
the mode of action is not likely to be through the accumulation
of formate. As suggested by some reports (Cook et al., 1991;
Kingsley and Hirsch, 1954), it may rather be attributable to
methanol itself.
The use of formate as a biomarker of exposure to methanol
is further limited by the fact that it is not a specific metabolite
of methanol exposure. Also, background concentrations of
formate are subject to wide interindividual variations (Bau-
mann and Angerer, 1979; D’Alessandro et al., 1994; Franzblau
et al., 1995; Heinrich and Angerer, 1982; Lee et al., 1992;
Osterloh et al., 1996; Sedivec et al., 1981). This leaves blood
and urinary methanol as the most appropriate biomarkers of
absorbed methanol. Since the model relates blood and urinary
methanol burdens to the exposure dose and body burdens of
metabolites at all time points, it can be of great use in recon-
structing past and present exposure levels starting from meth-
anol amounts in blood and urine.
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APPENDIX
Methanol Kinetics: First Order Linear Differential
Equations for Each Compartment
Kinetics of the Methanol Form
From Figure 1, the following differential equations are obtained
(see Table 1 for definitions of symbols):
dL(t)
dt 5 2 (kabs 1 kre) 3 L(t) 1 g(t) (1)
where g(t) is the pulmonary exposure dose per unit of time. g(t) 5
Cexp 3 VR where Cexp is the exposure concentration and VR is the
pulmonary ventilation rate. For an iv injection, g(t) 5 0 for t . 0 and
at time t 5 0, X(0) 5 100% of dose.
The fraction of absorption through the lungs can be defined as fabs 5
kabs/(kabs 1 kre).
dX(t)
dt 5 kabs 3 L(t) 2 (km 1 kex) 3 X(t) 2 kmet 3 h(X) 3 X(t) (2)
where
h(X) 5 KmKm 1 X(t)
Considering the rapid exchange rates between the various internal
organs and blood, and thus between the whole body burden and blood,
it can be considered that
X(t) 5 VdMeOH 3 B(t) (3)
where B(t) is the blood concentration of methanol as a function of
time.
dE(t)
dt 5 kre 3 L(t) 1 kex 3 X(t) (4)
dM(t)
dt 5 km 3 X(t) (5)
Kinetics of the Formaldehyde Form
dY(t)
dt 5 kmet 3 h(X) 3 X(t) 2 (kform 1 koth) 3 Y(t) (6)
The global breakdown rate of formaldehyde, kfald 5 kform 1 koth,
is very large compared to the subsequent transfer rates {ku and kCO2}
because observed formaldehyde levels are very small compared to
formate levels. This implies rapid breakdown of formaldehyde com-
pared to formate elimination rates. The rate of formaldehyde break-
down, kfald, was given the value reported by McMartin et al. (1979) in
cynomolgus monkeys, corresponding to a half-life of 1.5 min. How-
ever, its exact value is not relevant to the model’s unfolding, only the
ratios kform/kfald and koth/kfald are.
Kinetics of the Other Forms
dO(t)
dt 5 koth 3 Y(t) 2 kn 3 O(t) (7)
dN(t)






dt 5 koth 3 Y(t) (9)
Kinetics of the Formate Form
dZ(t)
dt 5 kform 3 Y(t) 2 (ku 1 kCO2) 3 Z(t) (10)
dF(t)
dt 5 ku 3 Z(t) (11)
dC(t)
dt 5 kCO2 3 Z(t) (12)
Mass Balance Verification
E(t) 1 L(t) 1 X(t) 1 M(t) 1 Y(t) 1 U(t) 1 Z(t) 1 F(t) 1 C(t)
2 (E(0) 1 L(0) 1 X(0) 1 M(0) 1 Y(0) 1 U(0) 1 Z(0)
1 F(0) 1 C(0)) 5 E
0
t
g(t) 3 dt 5 total exposure dose over time
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